Table 4.

Baseline characteristics of children who died by time of death after ART

Characteristics	≤3 months n=43	4-6 months n=17	7-12 months n=15	>12 months n=40
Age, years
<1	6 (14.0)	0	2 (13.3)	5 (12.5)
1-4	11 (25.6)	4 (23.5)	4 (26.7)	7 (17.5)
5-12	25 (58.1)	13 (76.5)	8 (53.3)	24 (60)
≥13	1 (2.3)	0	1 (6.7)	4 (10.0)
Median (IQR)	7.1 (2.9-9.4)	8.3 (6.3-11.3)	6.2 (1.9-8.7)	6.0 (4.0-9.2)
Baseline CD4%
<5	19 (44.2)	10 (58.8)	5 (33.3)	11 (27.5)
5-14	6 (14.0)	1(5.9)	5 (33.3)	6 (15.0)
15-24	4 (9.5)	0	0	0
≥25	1 (2.3)	0	1 (6.7)	2 (5.0)
Unknown	13 (30.2)	6 (35.3)	4 (26.7)	21 (52.5)
Median (IQR)	2.0 (1.0-7.0)	1.0 (0-1.3)	5.0 (1.0-13.0)	3.0 (1.5-12.0)
WHO stage
Stage 1/2	2 (4.7)	1(5.9)	0	3 (7.5)
Stage 3	15 (34.9)	1 (5.9)	2 (13.3)	16 (40.0)
Stage 4	23 (53.5)	12 (7.6)	9 (60.0)	11 (27.5)
Unknown	3 (7.0)	3 (17.7)	4 (26.7)	10 (25.0)
HIV-RNA
<10,000	0		0	0
10,000-99,999	1 (2.3)	3 (17.7)	0	1 (2.5)
≥100,000	5 (11.6)	1 (5.9)	2 (13.3)	5 (12.5)
Unknown	37 (86.1)	13 (76.5)	13 (86.7)	34 (85.0)
Severe anemia
Yes	3 (7.0)	1 (5.9)	3 (20.0)	2 (5.0)
No	31 (72.1)	10 (58.8)	9 (60.0)	20 (50.0)
Unknown	9 (20.9)	6 (35.3)	3 (20.0)	18 (45.0)
Median (IQR)	9.7 (7.6-10.6)	8.9 (8.1-10.2)	8.7 (7.2-10.0)	9.3 (8.2-2.8)
Weight for age z median (IQR)	-5.1 (-6.9 to -3.4)	-3.8 (-6.4 to -2.0)	-3.7 (-4.7 to -2.5)	-3.5 (-4.4 to -2.4)
BMI Median (IQR)	11.9 (10.5-14.1)	12.7 (12.0-14.4)	14.0 (12.9-14.8)	13.5 (12.3-15.5)

ART – antiretroviral therapy; IQR – interquartile range; BMI – body mass index